Cargando…

Alprazolam addiction: The case study

INTRODUCTION: Alprazolam is an anxiolytic, a benzodiazepine derivative of the middle duration of action. It is one of the most frequently prescribed medication for the treatment of anxiety and panic disorder. Under the action of a drug, a person feels incredible ease, a sense of euphoria, absence of...

Descripción completa

Detalles Bibliográficos
Autores principales: Pityk, O., Karbovskyi, N., Galyga, N., Rubanets, O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9480068/
http://dx.doi.org/10.1192/j.eurpsy.2021.1724
_version_ 1784790962679054336
author Pityk, O.
Karbovskyi, N.
Galyga, N.
Rubanets, O.
author_facet Pityk, O.
Karbovskyi, N.
Galyga, N.
Rubanets, O.
author_sort Pityk, O.
collection PubMed
description INTRODUCTION: Alprazolam is an anxiolytic, a benzodiazepine derivative of the middle duration of action. It is one of the most frequently prescribed medication for the treatment of anxiety and panic disorder. Under the action of a drug, a person feels incredible ease, a sense of euphoria, absence of problems, a sense of safety. OBJECTIVES: A 55-year woman was admitted to psychiatric clinic in Ivano - Frankivsk. METHODS: She was assesed by the clinicopsychopatological method (clinical interview) and additional methods (MRI, EEG, pathopsycological assessment). RESULTS: The main findings were: atactic procession, tremor of the limbs and the whole body, poor attention, speech impairment, retarded thinking, fixation and reproductive amnesia with the components of progressive amnesia, change handwriting. The mood is lowered with unstable affect, lack of insight. She reported burning and tingling of the head as a main problem. She developed amotivation, bad activity and drowsiness, bradycardia, decreased blood pressure. She took Alprazolam during a period of 1,5 year in gradually increasing doses. The last dose was 12 tablets of Alprazolam per day. The patient was consulted again in a year. She does not take Alprazolam. She takes valproate and escitalopram. She did not demonstrate severe neurological symptoms which were seen a year ago. CONCLUSIONS: Thus, though alprazolam is one of the best anxiolytic substance it should be prescribed only by the doctor for a short course (no more than 4-5 weeks). The treatment must include psychoeducation in order to make patients be aware about possible addiction and unsafety of prolonged and uncontrolled usage of alprazolam. DISCLOSURE: No significant relationships.
format Online
Article
Text
id pubmed-9480068
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-94800682022-09-29 Alprazolam addiction: The case study Pityk, O. Karbovskyi, N. Galyga, N. Rubanets, O. Eur Psychiatry Abstract INTRODUCTION: Alprazolam is an anxiolytic, a benzodiazepine derivative of the middle duration of action. It is one of the most frequently prescribed medication for the treatment of anxiety and panic disorder. Under the action of a drug, a person feels incredible ease, a sense of euphoria, absence of problems, a sense of safety. OBJECTIVES: A 55-year woman was admitted to psychiatric clinic in Ivano - Frankivsk. METHODS: She was assesed by the clinicopsychopatological method (clinical interview) and additional methods (MRI, EEG, pathopsycological assessment). RESULTS: The main findings were: atactic procession, tremor of the limbs and the whole body, poor attention, speech impairment, retarded thinking, fixation and reproductive amnesia with the components of progressive amnesia, change handwriting. The mood is lowered with unstable affect, lack of insight. She reported burning and tingling of the head as a main problem. She developed amotivation, bad activity and drowsiness, bradycardia, decreased blood pressure. She took Alprazolam during a period of 1,5 year in gradually increasing doses. The last dose was 12 tablets of Alprazolam per day. The patient was consulted again in a year. She does not take Alprazolam. She takes valproate and escitalopram. She did not demonstrate severe neurological symptoms which were seen a year ago. CONCLUSIONS: Thus, though alprazolam is one of the best anxiolytic substance it should be prescribed only by the doctor for a short course (no more than 4-5 weeks). The treatment must include psychoeducation in order to make patients be aware about possible addiction and unsafety of prolonged and uncontrolled usage of alprazolam. DISCLOSURE: No significant relationships. Cambridge University Press 2021-08-13 /pmc/articles/PMC9480068/ http://dx.doi.org/10.1192/j.eurpsy.2021.1724 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Pityk, O.
Karbovskyi, N.
Galyga, N.
Rubanets, O.
Alprazolam addiction: The case study
title Alprazolam addiction: The case study
title_full Alprazolam addiction: The case study
title_fullStr Alprazolam addiction: The case study
title_full_unstemmed Alprazolam addiction: The case study
title_short Alprazolam addiction: The case study
title_sort alprazolam addiction: the case study
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9480068/
http://dx.doi.org/10.1192/j.eurpsy.2021.1724
work_keys_str_mv AT pityko alprazolamaddictionthecasestudy
AT karbovskyin alprazolamaddictionthecasestudy
AT galygan alprazolamaddictionthecasestudy
AT rubanetso alprazolamaddictionthecasestudy